Perfect Medical Industry Co., Ltd.(TW:6543)
NT$16.55-0.50 (-2.93%)
TW:6543
Perfect Medical Industry Co., Ltd. financials statements
NT$16.55
At close:-0.50 (-2.93%)
Perfect Medical Industry Co., Ltd. (6543) Ratios
Perfect Medical Industry Co., Ltd. Ratios
TW:6543's free cash flow for Q2 2026 was NT$-127.48M. For the 2026 fiscal year, TW:6543's free cash flow was decreased by NT$-114.70M and operating cash flow was NT$-12.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.71 | 3.01 | 1.71 | 2.11 | 1.32 |
| Quick Ratio | 1.24 | 2.00 | 1.17 | 1.20 | 0.71 |
| Cash Ratio | 0.69 | 1.11 | 0.58 | 0.47 | 0.31 |
| Solvency Ratio | 0.23 | 0.47 | 0.30 | 0.23 | 0.19 |
| Operating Cash Flow Ratio | 0.28 | 0.77 | 0.54 | 0.53 | 0.01 |
| Short-Term Operating Cash Flow Coverage | 0.51 | 2.47 | 0.91 | 1.11 | 0.02 |
| Net Current Asset Value | NT$ 138.00M | NT$ 251.73M | NT$ 154.53M | NT$ 112.15M | NT$ 56.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.17 | 0.21 | 0.22 | 0.31 |
| Debt-to-Equity Ratio | 0.42 | 0.23 | 0.32 | 0.32 | 0.55 |
| Debt-to-Capital Ratio | 0.30 | 0.19 | 0.24 | 0.24 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.13 | 0.06 | 0.14 | 0.10 |
| Financial Leverage Ratio | 1.63 | 1.39 | 1.49 | 1.47 | 1.79 |
| Debt Service Coverage Ratio | 0.46 | 2.41 | 0.60 | 0.75 | 0.36 |
| Interest Coverage Ratio | 7.52 | 24.55 | 13.36 | 0.82 | 19.74 |
| Debt to Market Cap | 0.23 | 0.13 | 0.25 | 0.28 | 0.41 |
| Interest Debt Per Share | 6.51 | 3.83 | 4.69 | 4.73 | 7.81 |
| Net Debt to EBITDA | 0.69 | -0.13 | 0.44 | 1.48 | 1.76 |
| Profitability Margins | |||||
| Gross Profit Margin | 24.11% | 32.01% | 27.32% | 19.85% | 28.92% |
| EBIT Margin | 6.60% | 14.93% | 7.99% | 3.31% | 9.04% |
| EBITDA Margin | 15.26% | 22.49% | 15.73% | 11.56% | 15.75% |
| Operating Profit Margin | 6.60% | 12.27% | 7.95% | 0.54% | 8.07% |
| Pretax Profit Margin | 9.18% | 14.43% | 7.39% | 2.66% | 8.63% |
| Net Profit Margin | 6.96% | 11.98% | 5.46% | 2.11% | 5.35% |
| Continuous Operations Profit Margin | 6.96% | 11.98% | 5.46% | 2.11% | 5.35% |
| Net Income Per EBT | 75.83% | 83.00% | 73.89% | 79.38% | 62.02% |
| EBT Per EBIT | 139.13% | 117.58% | 92.94% | 492.36% | 106.87% |
| Return on Assets (ROA) | 4.04% | 7.99% | 4.06% | 1.49% | 3.74% |
| Return on Equity (ROE) | 6.59% | 11.09% | 6.04% | 2.20% | 6.71% |
| Return on Capital Employed (ROCE) | 5.37% | 9.84% | 8.23% | 0.48% | 9.03% |
| Return on Invested Capital (ROIC) | 3.33% | 7.67% | 4.93% | 0.34% | 4.04% |
| Return on Tangible Assets | 4.04% | 9.06% | 4.48% | 1.48% | 3.72% |
| Earnings Yield | 3.59% | 6.54% | 4.84% | 2.00% | 5.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.72 | 7.23 | 6.68 | 6.32 | 6.97 |
| Payables Turnover | 16.51 | 15.50 | 22.65 | 26.59 | 17.16 |
| Inventory Turnover | 3.30 | 2.69 | 3.47 | 3.01 | 2.15 |
| Fixed Asset Turnover | 1.36 | 1.75 | 1.94 | 1.69 | 1.87 |
| Asset Turnover | 0.58 | 0.67 | 0.74 | 0.71 | 0.70 |
| Working Capital Turnover Ratio | 2.40 | 2.59 | 3.49 | 3.91 | 4.23 |
| Cash Conversion Cycle | 152.23 | 162.65 | 143.61 | 165.17 | 200.92 |
| Days of Sales Outstanding | 63.85 | 50.47 | 54.63 | 57.80 | 52.36 |
| Days of Inventory Outstanding | 110.49 | 135.72 | 105.09 | 121.10 | 169.83 |
| Days of Payables Outstanding | 22.11 | 23.54 | 16.11 | 13.73 | 21.28 |
| Operating Cycle | 174.33 | 186.20 | 159.72 | 178.90 | 222.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.98 | 2.92 | 3.25 | 2.35 | 0.11 |
| Free Cash Flow Per Share | -1.62 | 0.90 | 1.81 | 1.18 | -2.40 |
| Dividend Paid and CapEx Coverage Ratio | 0.45 | 0.87 | 1.80 | 1.57 | 0.03 |
| Capital Expenditure Coverage Ratio | 0.55 | 1.45 | 2.26 | 2.00 | 0.04 |
| Operating Cash Flow Coverage Ratio | 0.31 | 0.78 | 0.71 | 0.51 | 0.01 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.19 | 0.20 | 0.16 | 0.01 |
| Free Cash Flow Yield | -5.84% | 3.25% | 10.10% | 7.41% | -13.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 27.75 | 15.30 | 20.88 | 49.59 | 19.72 |
| Price-to-Sales (P/S) Ratio | 1.94 | 1.83 | 1.13 | 1.05 | 1.05 |
| Price-to-Book (P/B) Ratio | 1.84 | 1.70 | 1.25 | 1.10 | 1.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.11 | 30.77 | 9.90 | 13.50 | -7.65 |
| Price-to-Operating Cash Flow Ratio | 14.03 | 9.50 | 5.52 | 6.76 | 170.65 |
| Price-to-Earnings Growth (PEG) Ratio | -0.62 | 0.14 | 0.12 | -0.76 | -0.32 |
| Enterprise Value Multiple | 13.41 | 8.01 | 7.60 | 10.60 | 8.40 |
| Enterprise Value | 1.59B | 1.34B | 878.14M | 829.24M | 958.95M |
| EV to EBITDA | 13.41 | 8.01 | 7.60 | 10.60 | 8.40 |
| EV to Sales | 2.05 | 1.80 | 1.20 | 1.22 | 1.32 |
| EV to Free Cash Flow | -18.04 | 30.27 | 10.51 | 15.69 | -9.67 |
| EV to Operating Cash Flow | 14.79 | 9.34 | 5.86 | 7.85 | 215.83 |
| Tangible Book Value Per Share | 15.11 | 14.24 | 12.39 | 14.45 | 13.98 |
| Shareholders’ Equity Per Share | 15.11 | 16.33 | 14.40 | 14.45 | 13.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.17 | 0.26 | 0.21 | 0.38 |
| Revenue Per Share | 14.30 | 15.12 | 15.93 | 15.06 | 17.53 |
| Net Income Per Share | 1.00 | 1.81 | 0.87 | 0.32 | 0.94 |
| Tax Burden | 0.76 | 0.83 | 0.74 | 0.79 | 0.62 |
| Interest Burden | 1.39 | 0.97 | 0.93 | 0.80 | 0.95 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.15 | 0.18 | 0.18 | 0.18 | 0.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.99 | 1.34 | 2.76 | 7.40 | 0.11 |
Currency in TWD
